(DEMO) Better Health

With Grand Solutions, Innovation Fund Denmark (IFD) wants to invest in ambitious innovation projects with excellent science and strategic research that contributes to create new and tangible solutions to important societal challenges and creates value for Denmark.

The FORSK2025 catalogue is the basis and guide for the thematic calls.

Health is vital for the life quality of citizens. The public health area accounts for a large proportion of public expenditure and the life science industry is important for Danish export and prosperity.

Objective

Objective With this Grand Solutions call, IFD addresses cross-disciplinary issues, challenges and needs, nationally as well as internationally, where research and innovation is the value-creating element for Denmark, through the development of solutions to Danish societal challenges, which – in the short or longer term – will create growth and employment in Denmark.

The Grand Solutions call Better Health strives to invest in knowledge-based and cross-disciplinary solutions for Danish society, paving the way for unprecedented societal and market opportunities.

Areas of Investments

The call is aimed at innovation projects with specific or cross-disciplinary development of service, innovative products and/or processes within all fields. The ambition is for the results to drive forward the future financial and/or societal development or to find solutions to significant societal challenges, for example by ensuring that Danish public and private companies can maintain and/or develop their competiveness, nationally and/or globally.

Non-limiting examples of healthcare related challenges and needs, which lies within this Grand Solutions call, concern e.g. cancer, neurological and psychiatric diseases, chronic diseases, antimicrobial resistance, as well as physical, psychological and chemical health and safety, including how physical and psychological attrition in e.g. construction industry and farming can best be reduced. Please see the FORSK2025 catalogue for further details.

Furthermore, the development within healthcare yields a strong Danish and international demand and need for new knowledge, clinical research, including metastudies of effects and side effects, psychotropic drugs versus non-pharmacological interventions, technology and solutions for better and cheaper prevention, diagnostics, treatment and rehabilitation in the somatic and psychiatric fields. In addition, personal medicine is a particularly promising area, where the potential gain for patients, healthcare and industry is significant e.g. within the cancer area, and where international research collaborations are important. 

DKK 25 mill. of the DKK 120 mill. are allocated to application-oriented and practice-oriented research in a citizen-based and technology-supported healthcare system. The research should help develop and implement technological solutions to support a well-functioning healthcare system and make the individual citizen more self-reliant, thus enhancing the individual’s personal freedom. The research may enable people to become more directly involved in prevention, treatment and rehabilitation through e.g. new technological developments. Furthermore, research may support the effective organisation of a cohesive healthcare service, where citizens and health professionals experience good patient care. This, amongst other things, may strengthen the research base for health training and competence development in the healthcare system.

Innovation projects within the present call, Better Health, may support the UN Sustainable Development Goal no. 3: Good health and well-being.

Theme Specific Strategy

IFD will contribute to the Danish life science ecosystem – consisting of research communities, companies and public institutions – enabling it to compete with the very best life science regions in the world.

IFD believes, that it is important to create value for patients and for Danish society through investments in projects dealing with disease treatment and/or chronically ill patients, as well as the organisation of healthcare in the most appropriate way for patients and society, e.g. seen in relation to rapid diagnosis and treatment in order to maintain the patient’s connection to the labour market. IFD thus welcomes projects regarding e.g. patient care and/or the dissemination of “best practice” methods within the general health area or within specific subject areas. In addition, IFD invests in projects aimed at improving biological disease understanding, new diagnostics and new treatment.

IFD invests in strategic science and research and innovative solutions within Better Health, which have a clearly defined aim and expected effect(s). Please also refer to IFD’s specific investment strategy for health and the listed guidelines for the allocation in FORSK2025.

Assessment Criteria

With the Better Health call, IFD invests in strategic research projects and innovative solutions, which have a clearly defined aim and expected impact. It is important that the aims are clearly defined, and the path to the goal is substantiated, for example that the project group comprises the necessary competences. The solutions must have considerable societal or market potential – short or long term. It is not a prerequisite that the project leads to a commercial product but it is a requirement that knowledge created in the project creates value by bringing the project forward in well-defined and value-creating steps towards new solutions.

IFD will always prioritise investing in excellent knowledge-based innovation projects providing solutions of the highest quality, regardless of subject and specific field.

The main assessment criteria are:

  • Quality of science, research and innovation
  • Value creation during and after the project period
  • Efficiency of project execution
  • Implementation of results

For applications for Grand Solutions 2019 Better Health, value creation is broadly defined as targeted activities leading to increased growth and employment through for example developing new products and services, creating more and value-creating jobs, increasing productivity, lowering social costs, reducing resource consumption or reducing climate and/or environmental impact and solving significant societal issues.

In the application, the partners must describe the tangible value creation in the project. Value creation is not restricted to monetary value but may also be, for example, health economy parametres, e.g. increased life expectancy, reduced burden of disease and treatment need, improved quality of life and reduced environmental impact etc.

IFD prioritises applications where the project creates measureable value for Denmark and the Danish society. The project must possess considerable potential and result in new solutions or products, for example through development and utilisation of new untraditional, potential disruptive business models, methods, smart regulations etc.

IFD invests in innovation projects having a clear recipient or beneficiary in mind and potential to become attractive for other investors. The issues and needs must be clear and the solutions should not be previously available (globally).  Further, the value creation should be measureable (e.g. health economics parameters, societal or monetary value).

IFD is willing to invest in high-risk projects if the partners also commit resources and knowledge to the project and if the risk is well described. Thus, the project governance model and quality of the project plan are crucial. Therefore, it is important that the recipients/beneficiaries and core stakeholders either participate to form the project, participate in the project or are otherwise involved in the project, e.g. through investment, and this will be taken into consideration when assessing the innovation project.

The application will be assessed specifically on the qualities of the project in relation to excellent science, research and innovation in a global perspective with respect to an articulated or latent unmet need, state-of-the-art, directly competitive or similar scientific or technological solutions, solution scalability, technical, regulatory and market risks, risk management in the project plan and project implementation. In addition, development rate, efficient use of invested resources, leadership and scientific skills and the subsequent efficient implementation of the project results nationally and/or globally will be carefully assessed. The project’s value creation will be assessed in relation to the size and risk of the investment.

Reference is made to Guidelines for Grand Solutions 2019.

The allocation of funds is based on the National Budget 2019 and FORSK2025 catalogue as listed in the National Budget, as well as the 2019 Allocation of the Research Reserve.

Advice and guidance

Questions and answers

Contact

The program

Application

Evaluation

From approval to project start

During the project

Guidelines and general terms and conditions

Process in case of missing consultation

Process in case of lack of recognized researcher

Sammenligning af EUDP- og Grand Solution-programmer

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.